Latest Entitlement Offers News

Optiscan Imaging Limited has launched a $17.75 million fully underwritten entitlement offer to fund clinical trials, regulatory approvals, and product development. Peters Investments underwrites the offer, potentially increasing its stake to nearly 39%.

Optiscan Imaging Ltd has launched a fully underwritten $17.75 million entitlement offer to fund clinical trials and regulatory clearances for its medical devices, marking a pivotal step in its transition to a commercial medical device manufacturer.

Invion Limited posted a $8.8 million loss for FY25, marking a 56.5% increase, while advancing clinical trials and securing fresh capital. The biotech faces a going concern warning amid ongoing development and funding challenges.

archTIS Limited has reported FY25 results with solid ARR growth and completed a transformative acquisition of Spirion LLC, significantly boosting its US market presence and product suite. The company is raising $20.5 million to fund this expansion and accelerate growth.

archTIS Limited has acquired Spirion LLC’s technology, customers, and employees for A$15.7 million, significantly expanding its U.S. presence and product portfolio in data security. The deal adds A$17 million in annual recurring revenue and brings new cross-selling opportunities across a blue-chip customer base.

MRG Metals has successfully raised over $500,000 through an entitlement offer, issuing new options to fund exploration in Mozambique while directors fully subscribed and plan further participation.

MA Credit Income Trust (ASX, MA1) has announced a $190.5 million non-renounceable entitlement offer at a 3.4% discount, aiming to bolster its private credit investments across asset-backed, direct asset, and corporate lending sectors.

AnteoTech Ltd reported a 110% revenue increase to A$968,878 in FY2025 alongside a 24% reduction in net loss, driven by strategic cost savings and key partnerships. Leadership renewal and product validation position the company for growth in battery and life sciences markets.

Vonex Limited reported a significant reduction in net loss alongside operational improvements and a strengthened balance sheet, while advancing a major acquisition scheme with MaxoTel.

Vonex Limited reported a significantly reduced net loss for FY25 alongside a strengthened balance sheet, operational upgrades, and a pending acquisition by Maxo Telecommunications. The company is navigating going concern uncertainties while advancing network expansion and governance reforms.

Terragen Holdings reported a $3.72 million loss for FY25, impacted by drought and lower revenues, while launching dry probiotic products targeting feedlots and completing a $4.76 million equity raise.

Elanor Commercial Property Fund reported a statutory loss for FY25 but delivered a 6.9% rise in Funds from Operations, while rejecting an unsolicited takeover offer from the Lederer Group.